Financials Shanghai Fudan Forward S&T Co., Ltd

Equities

600624

CNE0000006S1

Pharmaceuticals

End-of-day quote Shanghai S.E. 06:00:00 2024-05-07 pm EDT 5-day change 1st Jan Change
4.19 CNY -0.48% Intraday chart for Shanghai Fudan Forward S&T Co., Ltd +1.95% -26.62%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 4,143 6,635 5,361 4,737 3,886 3,879
Enterprise Value (EV) 1 4,198 6,725 5,467 4,932 4,093 4,090
P/E ratio 97.6 x 120 x -95.5 x -45 x -1,078 x 634 x
Yield 0.41% 0.28% - - - -
Capitalization / Revenue 4.11 x 4.74 x 5.7 x 4.55 x 4.93 x 5.71 x
EV / Revenue 4.16 x 4.8 x 5.81 x 4.74 x 5.19 x 6.02 x
EV / EBITDA 60.7 x 63.6 x 63 x 48.9 x 123 x 94.1 x
EV / FCF 87.2 x -192 x 185 x 132 x -179 x 26.1 x
FCF Yield 1.15% -0.52% 0.54% 0.76% -0.56% 3.83%
Price to Book 3.61 x 5.61 x 4.86 x 5.17 x 4.4 x 4.22 x
Nbr of stocks (in thousands) 684,712 684,712 684,712 683,512 679,347 679,347
Reference price 2 6.050 9.690 7.830 6.930 5.720 5.710
Announcement Date 4/19/19 4/24/20 4/29/21 4/29/22 4/28/23 4/29/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 1,008 1,400 940.3 1,041 789 679.7
EBITDA 1 69.2 105.7 86.75 100.9 33.17 43.49
EBIT 1 44.46 81.26 62.38 75.91 8.631 3.406
Operating Margin 4.41% 5.8% 6.63% 7.29% 1.09% 0.5%
Earnings before Tax (EBT) 1 65.22 84.08 -36.44 -66.63 3.922 23.48
Net income 1 42.79 55.51 -55.83 -105.4 -3.61 5.963
Net margin 4.24% 3.97% -5.94% -10.12% -0.46% 0.88%
EPS 2 0.0620 0.0810 -0.0820 -0.1540 -0.005306 0.009000
Free Cash Flow 1 48.14 -35.1 29.51 37.48 -22.85 156.6
FCF margin 4.77% -2.51% 3.14% 3.6% -2.9% 23.04%
FCF Conversion (EBITDA) 69.57% - 34.02% 37.15% - 360.1%
FCF Conversion (Net income) 112.51% - - - - 2,626.09%
Dividend per Share 2 0.0250 0.0270 - - - -
Announcement Date 4/19/19 4/24/20 4/29/21 4/29/22 4/28/23 4/29/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 55.7 90.5 106 195 207 211
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 0.8044 x 0.8557 x 1.224 x 1.935 x 6.236 x 4.856 x
Free Cash Flow 1 48.1 -35.1 29.5 37.5 -22.8 157
ROE (net income / shareholders' equity) 4.1% 4.92% -4.17% -9.55% 0.07% 0.74%
ROA (Net income/ Total Assets) 1.11% 2.13% 1.85% 2.37% 0.29% 0.12%
Assets 1 3,850 2,608 -3,022 -4,453 -1,264 5,127
Book Value Per Share 2 1.680 1.730 1.610 1.340 1.300 1.350
Cash Flow per Share 2 0.5200 0.4300 0.4500 0.4500 0.4600 0.5100
Capex 1 15.8 13.2 19.6 26.9 20.9 7.51
Capex / Sales 1.57% 0.94% 2.08% 2.59% 2.65% 1.1%
Announcement Date 4/19/19 4/24/20 4/29/21 4/29/22 4/28/23 4/29/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. 600624 Stock
  4. Financials Shanghai Fudan Forward S&T Co., Ltd
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW